Guest Editorial Oncology providers, advocates form LGBTQ+ community group at ASCO with focus on research, education, equity June 21, 2024Vol.50 No.25By Don S. Dizon, Chunkit Fung, Paula Chambers Raney, Charles Kamen and Shail Maingi
FreeObituary Nathan Berger, founding director of Case Comprehensive Cancer Center, dies at 83 June 21, 2024Vol.50 No.25By Case Comprehensive Cancer Center
Cancer History ProjectFree Remembering the day 22 years ago when ODAC debated the Iressa quandary June 21, 2024Vol.50 No.25By Paul Goldberg
FreeIn the Archives Two years before the role of EGFR mutations was understood, ODAC recommended accelerated approval of Iressa for NSCLC June 21, 2024Vol.50 No.25
NCI NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines June 14, 2024Vol.50 No.24By Matthew Bin Han Ong
FreeObituary “Father of tamoxifen” V. Craig Jordan dies at 76 June 14, 2024Vol.50 No.24By MD Anderson Cancer Center staff
Trials & Tribulations The thorny road to drug approval for myelodysplastic syndromes June 14, 2024Vol.50 No.24By Mikkael A. Sekeres
FreeGuest Editorial Cancer centers, health providers should clearly signal that they welcome LGBTQI+ patients June 14, 2024Vol.50 No.24By NFN Scout
FreeIn the Archives In an interview and a memoir, V. Craig Jordan spoke about his life and SERMs June 14, 2024Vol.50 No.24
EditorialFree The Cancer Letter receives six journalism, design awards June 14, 2024Vol.50 No.24By Katie Goldberg
